Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 WNT pathway signaling is associated with microvascular injury and predicts kidney transplant failureAmerican Journal of Transplantation.  19:2833-2845. 2019
2019 CYP3A5 genotype affects time to therapeutic tacrolimus level in pediatric kidney transplant recipientsPediatric Transplantation.  23. 2019
2018 Subclinical inflammation phenotypes and long-term outcomes after pediatric kidney transplantationAmerican Journal of Transplantation.  18:2189-2199. 2018
2017 Responsiveness of the PROMIS® measures to changes in disease status among pediatric nephrotic syndrome patients: A Midwest pediatric nephrology consortium studyHealth and Quality of Life Outcomes.  15. 2017
2017 Polyomavirus reactivation and immune responses to kidney-specific self-antigens in transplantationJournal of the American Society of Nephrology.  28:1314-1325. 2017
2016 Fibroblast growth factor-23 and chronic allograft injury in pediatric renal transplant recipients: A Midwest Pediatric Nephrology Consortium studyPediatric Transplantation.  20:378-387. 2016
2016 Vitamin D in incident nephrotic syndrome: a Midwest Pediatric Nephrology Consortium studyPediatric Nephrology.  31:465-472. 2016
2016 Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney diseaseKidney International.  89:1231-1243. 2016
2016 The kidney-vascular-bone axis in the chronic kidney disease-mineral bone disorderTransplantation.  100:497-505. 2016
2015 The impact of disease duration on quality of life in children with nephrotic syndrome: a Midwest Pediatric Nephrology Consortium studyPediatric Nephrology.  30:1467-1476. 2015
2015 Pathophysiology of the chronic kidney disease - Mineral bone disorderCurrent Opinion in Nephrology and Hypertension.  24:303-309. 2015
2015 Kidney transplant results in children: Progress made, but blacks lag behindKidney International.  87:492-494. 2015
2015 Modernization of Chronic Allograft Injury Research: Better Biomarkers, Better Studies, Better Outcomes.Clinical Transplants.  31:211-225. 2015
2014 CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorderJournal of the American Society of Nephrology.  25:1760-1773. 2014
2014 Cytomegalovirus and anemia: Not just for transplant anymoreJournal of the American Society of Nephrology.  25:1613-1615. 2014
2014 Left ventricular mass progression despite stable blood pressure and kidney function in stage 3 chronic kidney diseaseAmerican Journal of Nephrology.  39:392-399. 2014
2013 Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney diseaseAmerican Journal of Nephrology.  38:158-167. 2013
2013 VEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipientsThe Journal of heart transplantation.  32:120-128. 2013
2012 Azithromycin decolonization of STECĝ€"a new risk emergesNature Reviews Nephrology.  8:429. 2012
2012 Therapy: Azithromycin and decolonization after HUSNature Reviews Nephrology.  8:317-318. 2012
2012 Second trimester anti-angiogenic proteins and preeclampsiaPregnancy Hypertension.  2:158-163. 2012
2010 Hyponatremia is Associated with Increased Severity of Disease in Critically Ill Children with BronchiolitisInternational Journal of Clinical Medicine.  01:37-40. 2010
2009 Acquired coarctation of the abdominal aorta related to umbilical artery catheterizationConnecticut Medicine.  73:273-276. 2009
2009 Hypokalemia and nocturia in a 15-year-old girlClinical Pediatrics.  48:317-319. 2009
2000 One-stage Soave pull-through for Hirschsprung's disease: A comparison of the transanal and open approachesJournal of Pediatric Surgery.  35:820-822. 2000

Chapter

Year Title Altmetric
2015 Disorders of Mineral and Bone Metabolism in Chronic Kidney Disease.  320-331. 2015
2013 Pathophysiology of Chronic Kidney Disease Mineral Bone Disorder (CKD-MBD).  632-639. 2013

Investigator On

  • APOL1 Long-Term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2019 - 2022
  • APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2017 - 2022
  • Private Grant  awarded by Genentech 2018 - 2021
  • Private Grant  awarded by Sanofi US Services Inc 2017 - 2021
  • Chronic Kidney Disease in Children CKID IV  awarded by CHILDREN'S MERCY HOSPITAL 2018 - 2020
  • The Child-Centered Outcomes in Practice and Research (COPR) Center of Excellence: Strengthing the Clinical Validity Evidence Base for PROMIS Measures in Chronically Ill Children  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2015 - 2019
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC. 2016 - 2019
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2016 - 2019
  • Private Grant  awarded by VIFOR 2016 - 2019
  • Phase 2 Study of Selective Cytopheretic Device for the Treatment of Pediatric Patients with Acute Kidney Injury  awarded by CINCINNATI CHILDREN'S HOSPITAL 2015 - 2019
  • Private Grant  awarded by OCTAPHARMA - NEW 2016 - 2019
  • Cure Glomerulonephropathy (CureGN): Integrative Proteomics & Metabolomics for Pediatric Glomerula Disease Biomarkers  awarded by NATIONWIDE CHILDREN'S HOSPITAL 2015 - 2018
  • Chronic Kidney Disease in Children (CKiD III)  awarded by CHILDREN'S MERCY HOSPITAL 2013 - 2018
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2013 - 2018
  • Private Grant  awarded by OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC 2016 - 2017
  • International Pediatric Peritoneal Biopsy Study in Children  awarded by UNIVERSITY OF HEIDELBERG 2015 - 2016
  • Education And Training

  • Doctor of Medicine, University of Connecticut 2004
  • University of Connecticut, Residency 2007
  • Boston Children's Hospital, Postdoctoral Fellowship 2010
  • Full Name

  • Michael Seifert